34
35 / 5% D 2005 / / / / VB M&A First-Tier M&A
IMS Health 'Strategic Market Review: Overview of 2004 and Key Trend for 2005' Copyright 2006 IMS Health or its affiliates, Source: IMS Health MIDAS, Reprinted with permission 36
IMS Health 'Strategic Market Review: Overview of 2004 and Key Trend for 2005' Copyright 2006 IMS Health or its affiliates, Source: IMS Health MIDAS, Reprinted with permission 37
38
IMS Health 'RetailDrugMonitor' Copyright 2006 IMS Health or its affiliates, Source: IMS Health : Retail Drug Monitor, Reprinted with permission 39
HHS, National Health Expenditure 40
HHS, National Health Expenditure HHS, National Health Expenditure 41
42 US Bureau of Labor Statistics, CPI
14% 12% 10% 10.9 12.9 13.9 11.2 8% 8.2 6% 4% 5.3 2% 0% 1999 2000 2001 2002 2003 2004 Kaiser Foundation, Employer Health Benefits, Annual Survey, 2004 43
$240 $220 $200 $180 $160 $140 $120 $100 $80 $60 $40 $20 $0 $34 $37 $8 $28 Kaiser Foundation, Employer Health Benefits, Annual Survey, 2004 $50 $48 $45 $40 $35 $33 $30 2004 $29 2003 $25 $25 2002 $21 2001 $20 $19 $20 2000 $17 $17 $15 $15 $13 $10 $7 $10 $8 $9 $9 $5 $0 GENERIC DRUGS PREFERRED DRUGS NONPREFERRED DRUGS FOUR-TIER DRUGS $222 $201 $178 $149 $135 $124 $122 $52 $47 $39 $42 $30 1988 1993 1996 2000 2001 2002 2003 2004 1988 1993 1996 2000 2001 20022003 2004 SINGLECONVERAGE FAMILYCOVERAGE Kaiser Foundation, Employer Health Benefits, Annual Survey, 2004 44
Kaiser Foundation, Employer Health Benefits, Annual Survey, 2004 45
46 HHS HHS, National Health Expenditure
Medco Drug Trend Report, Vol7, 2005, CMS Health Care Financing Review, Age Estimates in the National Health Accounts, Dec, 2004 47
Kaiser Foundation, Employer Health Benefits, Annual Survey, 2004 D 4,020 1999 CBO, Issue in Designing a Prescription Drug Benefit for Medicare 48
D 2005 18% 29% 39% 47% 4% Health Affairs, U.S. Health Spending Projections For 2004-20014 2% 4% D 2006 9% 20% 28% 49
50
51
IMS Health, Retail Drug Monitor Copyright 2006 IMS Health or its affiliates, Source: IMS Health : Retail Drug Monitor, Reprinted with permission IR 2005 GSK 2004 52
Medco, Drug Trend Report, Vol7, 2005 53
2004 Medco, Drug Trend Report, Vol7, 2005 IR 54
M&A IR 55
IR 56
J&J 57
58
IMS Health, Retail Drug Monitor Copyright 2006 IMS Health or its affiliates, Source: IMS Health : Retail Drug Monitor, Reprinted with permission 59
60
61
BMS 62
IR 63
IR 64
IR 65
IR 66
67
68 VB First Tier
FDA, CDER Drug and Biologic Approval Reports 69
70
71 J&J
72
73 IR
IR 2004 12 2005 3 74
- - - - - - - - - - - - - - - - - - - - 75
- - - - - - - - - - - - - - - - - - 76